BCDA
BioCardia, Inc.$1.15-0.01 (-0.86%)Prev Close$1.16·MCap$7.4M·P/E—·Vol63.2K·Yield—
▲
Buys (12M)
18
$1.15M
▼
Sells (12M)
3
$138.4K
◆
Net Activity
Net Buyer
$1.01M
●
Active Insiders
7
last 12 mo
Over the past 12 months, insider activity at BioCardia, Inc. (BCDA) has been dominated by buying, with 18 insider purchases totaling $1.15M and 3 insider sales totaling $138.4K. The most recent insider transaction was by Altman Peter (director, officer: President and CEO), who purchased $1.2K worth of shares on Apr 22, 2026. BioCardia, Inc. operates in the Healthcare sector, within the Biotechnology industry, with a market cap of $7.4M.
BCDA Insider Trading Activity
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Apr 22, 2026 | Altman Peter | director, officer: President and CEO | Buy | 1,000 | $1.23 | $1.2K | 275,766 |
| Mar 26, 2026 | Altman Peter | director, officer: President and CEO | Buy | 900 | $1.23 | $1.1K | 274,766 |
| Feb 4, 2026 | Altman Peter | President and CEO | Buy | 5,000 | $1.13 | $5.7K | 0 |
| Jan 20, 2026 | Altman Peter | President and CEO | Buy | 900 | $1.33 | $1.2K | 0 |
| Dec 16, 2025 | Altman Peter | President and CEO | Buy | 1,100 | $1.31 | $1.4K | 0 |
| Dec 8, 2025 | Altman Peter | President and CEO | Sell | 56,484 | $1.37 | $77.4K1.0% OS | 0 |
| Dec 8, 2025 | GILLIS EDWARD M | Senior Vice President, Devices | Sell | 15,172 | $1.37 | $20.8K | 0 |
| Dec 8, 2025 | McClung David | Chief Financial Officer | Sell | 29,339 | $1.37 | $40.2K0.5% OS | 0 |
| Sep 19, 2025 | Altman Peter | President and CEO | Buy | 48,000 | $1.25 | $60.0K0.8% OS | 0 |
| Sep 19, 2025 | Blank Andrew Scott | Director | Buy | 288,000 | $1.25 | $360.0K5.0% OS | 0 |
| Sep 19, 2025 | STERTZER SIMON H | Director | Buy | 398,400 | $1.25 | $498.0K6.9% OS | 0 |
| Aug 22, 2025 | Altman Peter | President and CEO | Buy | 700 | $1.83 | $1.3K | 0 |
| Aug 13, 2025 | Altman Peter | President and CEO | Buy | 100 | $1.83 | $183.00 | 0 |
| Aug 12, 2025 | Altman Peter | President and CEO | Buy | 400 | $1.75 | $700.40 | 0 |
| Aug 11, 2025 | Altman Peter | President and CEO | Buy | 1,700 | $1.76 | $3.0K | 0 |
| Jun 30, 2025 | Altman Peter | President and CEO | Buy | 24,096 | $2.08 | $50.0K | 0 |
| Jun 30, 2025 | McClung David | Chief Financial Officer | Buy | 4,819 | $2.08 | $10.0K | 0 |
| Jun 30, 2025 | STERTZER SIMON H | Director | Buy | 72,289 | $2.08 | $150.0K1.2% OS | 0 |
| May 30, 2025 | Altman Peter | President and CEO | Buy | 100 | $2.21 | $221.00 | 0 |
| May 20, 2025 | Altman Peter | President and CEO | Buy | 2,300 | $2.02 | $4.7K | 0 |
| May 14, 2025 | Altman Peter | President and CEO | Buy | 400 | $2.57 | $1.0K | 0 |
| Apr 23, 2025 | Altman Peter | President and CEO | Buy | 26,246 | $1.90 | $50.0K | 0 |
| Apr 23, 2025 | Blank Andrew Scott | Director | Buy | 131,233 | $1.91 | $250.0K2.3% OS | 0 |
| Apr 23, 2025 | KRASNO RICHARD M | Director | Buy | 13,123 | $1.90 | $25.0K | 0 |
| Apr 23, 2025 | STERTZER SIMON H | Director | Buy | 104,986 | $1.90 | $200.0K1.8% OS | 0 |
| Apr 15, 2025 | Altman Peter | President and CEO | Buy | 100 | $2.14 | $214.00 | 0 |
| Apr 10, 2025 | Altman Peter | President and CEO | Buy | 600 | $2.01 | $1.2K | 0 |
| Apr 7, 2025 | Altman Peter | President and CEO | Buy | 500 | $1.96 | $980.00 | 0 |
| Apr 4, 2025 | Altman Peter | President and CEO | Buy | 800 | $2.04 | $1.6K | 0 |
| Apr 3, 2025 | Altman Peter | President and CEO | Buy | 1,200 | $2.24 | $2.7K | 0 |
| Apr 2, 2025 | Altman Peter | President and CEO | Buy | 1,100 | $2.21 | $2.4K | 0 |
| Mar 5, 2025 | STERTZER SIMON H | Director | Buy | 1,000 | $2.45 | $2.5K | 0 |
| Mar 3, 2025 | Altman Peter | President and CEO | Buy | 500 | $2.11 | $1.1K | 0 |
| Mar 3, 2025 | STERTZER SIMON H | Director | Buy | 38,289 | $2.30 | $88.1K0.7% OS | 0 |
| Feb 7, 2025 | Altman Peter | President and CEO | Buy | 600 | $2.48 | $1.5K | 0 |
| Jan 29, 2025 | Altman Peter | President and CEO | Buy | 739 | $2.39 | $1.8K | 0 |
| Dec 23, 2024 | Altman Peter | President and CEO | Buy | 1,000 | $2.06 | $2.1K | 0 |
| Dec 20, 2024 | GILLIS EDWARD M | Senior Vice President, Devices | Sell | 3,257 | $2.00 | $6.5K | 0 |
| Dec 5, 2024 | Altman Peter | President and CEO | Buy | 250 | $2.22 | $555.00 | 0 |
| Nov 15, 2024 | Altman Peter | President and CEO | Buy | 1,350 | $1.87 | $2.5K | 0 |
| Oct 11, 2024 | Altman Peter | President and CEO | Sell | 21,680 | $2.65 | $57.5K | 0 |
| Oct 11, 2024 | GILLIS EDWARD M | Senior Vice President, Devices | Sell | 6,840 | $2.65 | $18.1K | 0 |
| Oct 11, 2024 | McClung David | Chief Financial Officer | Sell | 11,565 | $2.65 | $30.6K | 0 |
| Jun 28, 2024 | Altman Peter | President and CEO | Buy | 500 | $3.03 | $1.5K | 0 |
| Jun 21, 2024 | Altman Peter | President and CEO | Buy | 500 | $3.29 | $1.6K | 0 |
| Jun 14, 2024 | Altman Peter | President and CEO | Buy | 500 | $3.52 | $1.8K | 0 |
| Jun 10, 2024 | Altman Peter | President and CEO | Buy | 1,000 | $3.36 | $3.4K | 0 |
| Apr 19, 2024 | Altman Peter | President and CEO | Buy | 2,750 | $0.37 | $1.0K | 0 |
| Mar 28, 2024 | Altman Peter | President and CEO | Buy | 500 | $0.39 | $195.00 | 0 |
| Feb 13, 2024 | Altman Peter | President and CEO | Buy | 108,108 | $0.46 | $50.0K1.9% OS | 0 |
Showing 1–50 of 73
1 / 2
BCDA Insider Buying Activity
The following table shows recent insider purchases of BioCardia, Inc. (BCDA) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Apr 22, 2026 | Altman Peter | director, officer: President and CEO | Buy | 1,000 | $1.23 | $1.2K | 275,766 |
| Mar 26, 2026 | Altman Peter | director, officer: President and CEO | Buy | 900 | $1.23 | $1.1K | 274,766 |
| Feb 4, 2026 | Altman Peter | President and CEO | Buy | 5,000 | $1.13 | $5.7K | 0 |
| Jan 20, 2026 | Altman Peter | President and CEO | Buy | 900 | $1.33 | $1.2K | 0 |
| Dec 16, 2025 | Altman Peter | President and CEO | Buy | 1,100 | $1.31 | $1.4K | 0 |
| Sep 19, 2025 | Altman Peter | President and CEO | Buy | 48,000 | $1.25 | $60.0K0.8% OS | 0 |
| Sep 19, 2025 | Blank Andrew Scott | Director | Buy | 288,000 | $1.25 | $360.0K5.0% OS | 0 |
| Sep 19, 2025 | STERTZER SIMON H | Director | Buy | 398,400 | $1.25 | $498.0K6.9% OS | 0 |
| Aug 22, 2025 | Altman Peter | President and CEO | Buy | 700 | $1.83 | $1.3K | 0 |
| Aug 13, 2025 | Altman Peter | President and CEO | Buy | 100 | $1.83 | $183.00 | 0 |
| Aug 12, 2025 | Altman Peter | President and CEO | Buy | 400 | $1.75 | $700.40 | 0 |
| Aug 11, 2025 | Altman Peter | President and CEO | Buy | 1,700 | $1.76 | $3.0K | 0 |
| Jun 30, 2025 | Altman Peter | President and CEO | Buy | 24,096 | $2.08 | $50.0K | 0 |
| Jun 30, 2025 | McClung David | Chief Financial Officer | Buy | 4,819 | $2.08 | $10.0K | 0 |
| Jun 30, 2025 | STERTZER SIMON H | Director | Buy | 72,289 | $2.08 | $150.0K1.2% OS | 0 |
| May 30, 2025 | Altman Peter | President and CEO | Buy | 100 | $2.21 | $221.00 | 0 |
| May 20, 2025 | Altman Peter | President and CEO | Buy | 2,300 | $2.02 | $4.7K | 0 |
| May 14, 2025 | Altman Peter | President and CEO | Buy | 400 | $2.57 | $1.0K | 0 |
| Apr 23, 2025 | Altman Peter | President and CEO | Buy | 26,246 | $1.90 | $50.0K | 0 |
| Apr 23, 2025 | Blank Andrew Scott | Director | Buy | 131,233 | $1.91 | $250.0K2.3% OS | 0 |
| Apr 23, 2025 | KRASNO RICHARD M | Director | Buy | 13,123 | $1.90 | $25.0K | 0 |
| Apr 23, 2025 | STERTZER SIMON H | Director | Buy | 104,986 | $1.90 | $200.0K1.8% OS | 0 |
| Apr 15, 2025 | Altman Peter | President and CEO | Buy | 100 | $2.14 | $214.00 | 0 |
| Apr 10, 2025 | Altman Peter | President and CEO | Buy | 600 | $2.01 | $1.2K | 0 |
| Apr 7, 2025 | Altman Peter | President and CEO | Buy | 500 | $1.96 | $980.00 | 0 |
| Apr 4, 2025 | Altman Peter | President and CEO | Buy | 800 | $2.04 | $1.6K | 0 |
| Apr 3, 2025 | Altman Peter | President and CEO | Buy | 1,200 | $2.24 | $2.7K | 0 |
| Apr 2, 2025 | Altman Peter | President and CEO | Buy | 1,100 | $2.21 | $2.4K | 0 |
| Mar 5, 2025 | STERTZER SIMON H | Director | Buy | 1,000 | $2.45 | $2.5K | 0 |
| Mar 3, 2025 | Altman Peter | President and CEO | Buy | 500 | $2.11 | $1.1K | 0 |
| Mar 3, 2025 | STERTZER SIMON H | Director | Buy | 38,289 | $2.30 | $88.1K0.7% OS | 0 |
| Feb 7, 2025 | Altman Peter | President and CEO | Buy | 600 | $2.48 | $1.5K | 0 |
| Jan 29, 2025 | Altman Peter | President and CEO | Buy | 739 | $2.39 | $1.8K | 0 |
| Dec 23, 2024 | Altman Peter | President and CEO | Buy | 1,000 | $2.06 | $2.1K | 0 |
| Dec 5, 2024 | Altman Peter | President and CEO | Buy | 250 | $2.22 | $555.00 | 0 |
| Nov 15, 2024 | Altman Peter | President and CEO | Buy | 1,350 | $1.87 | $2.5K | 0 |
| Jun 28, 2024 | Altman Peter | President and CEO | Buy | 500 | $3.03 | $1.5K | 0 |
| Jun 21, 2024 | Altman Peter | President and CEO | Buy | 500 | $3.29 | $1.6K | 0 |
| Jun 14, 2024 | Altman Peter | President and CEO | Buy | 500 | $3.52 | $1.8K | 0 |
| Jun 10, 2024 | Altman Peter | President and CEO | Buy | 1,000 | $3.36 | $3.4K | 0 |
| Apr 19, 2024 | Altman Peter | President and CEO | Buy | 2,750 | $0.37 | $1.0K | 0 |
| Mar 28, 2024 | Altman Peter | President and CEO | Buy | 500 | $0.39 | $195.00 | 0 |
| Feb 13, 2024 | Altman Peter | President and CEO | Buy | 108,108 | $0.46 | $50.0K1.9% OS | 0 |
BCDA Insider Selling Activity
The following table shows recent insider sales of BioCardia, Inc. (BCDA) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Dec 8, 2025 | Altman Peter | President and CEO | Sell | 56,484 | $1.37 | $77.4K1.0% OS | 0 |
| Dec 8, 2025 | GILLIS EDWARD M | Senior Vice President, Devices | Sell | 15,172 | $1.37 | $20.8K | 0 |
| Dec 8, 2025 | McClung David | Chief Financial Officer | Sell | 29,339 | $1.37 | $40.2K0.5% OS | 0 |
| Dec 20, 2024 | GILLIS EDWARD M | Senior Vice President, Devices | Sell | 3,257 | $2.00 | $6.5K | 0 |
| Oct 11, 2024 | Altman Peter | President and CEO | Sell | 21,680 | $2.65 | $57.5K | 0 |
| Oct 11, 2024 | GILLIS EDWARD M | Senior Vice President, Devices | Sell | 6,840 | $2.65 | $18.1K | 0 |
| Oct 11, 2024 | McClung David | Chief Financial Officer | Sell | 11,565 | $2.65 | $30.6K | 0 |
BCDA Insiders
Similar Stocks to BCDA
VRTX
Vertex Pharmaceuticals Incorporated
$429.19+0.77%
$111.71B
REGN
Regeneron Pharmaceuticals, Inc.
$740.38-0.55%
$77.87B
ALNY
Alnylam Pharmaceuticals, Inc.
$305.79-0.88%
$41.24B
INSM
Insmed Incorporated
$133.47-1.85%
$30.79B
RVMD
Revolution Medicines, Inc.
$146.58+11.18%
$29.51B
UTHR
United Therapeutics Corporation
$566.52-0.06%
$25.13B
MRNA
Moderna, Inc.
$46.88-3.78%
$21.42B
RPRX
Royalty Pharma plc
$49.86+0.42%
$21.20B